Követés
Moisi Madalina
Moisi Madalina
Universitatea din Oradea
Nincs ellenőrzött e-mail-cím
Cím
Hivatkozott rá
Hivatkozott rá
Év
Oxidative stress–complex pathological issues concerning the hallmark of cardiovascular and metabolic disorders
D Rotariu, EE Babes, DM Tit, M Moisi, C Bustea, M Stoicescu, AF Radu, ...
Biomedicine & Pharmacotherapy 152, 113238, 2022
872022
Acute coronary syndromes in chronic kidney disease: clinical and therapeutic characteristics
MI Moisi, M Rus, S Bungau, DC Zaha, D Uivarosan, O Fratila, DM Tit, ...
Medicina 56 (3), 118, 2020
442020
Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy
EE Babes, C Bustea, T Behl, MM Abdel-Daim, AC Nechifor, M Stoicescu, ...
Biomedicine & Pharmacotherapy 148, 112772, 2022
362022
Vitamin D implications and effect of supplementation in endocrine disorders: autoimmune thyroid disorders (Hashimoto’s disease and Grave’s disease), diabetes mellitus and obesity
D Galușca, MS Popoviciu, EE Babeș, M Vidican, AA Zaha, VV Babeș, ...
Medicina 58 (2), 194, 2022
222022
Framing cause-effect relationship of acute coronary syndrome in patients with chronic kidney disease
MI Moisi, SG Bungau, CM Vesa, CC Diaconu, T Behl, M Stoicescu, ...
Diagnostics 11 (8), 1518, 2021
202021
A narrative review of the classical and modern diagnostic methods of the no-reflow phenomenon
LR Pantea-Roșan, SG Bungau, AF Radu, VA Pantea, MI Moisi, CM Vesa, ...
Diagnostics 12 (4), 932, 2022
92022
Cross-Sectional Study on a Population of Diabetes Mellitus Newly Diagnosed Patients. Relative Risk of Coronary Heart Disease (CHD) Morbidity Using UKPDS Risk Engine
VC Mihai, ZC Dana, P Loredana, CP Petrișor, M Mădălina, P Mircea, ...
Internal Medicine 15 (1), 7-15, 2018
72018
Reviewing the Modern Therapeutical Options and the Outcomes of Sacubitril/Valsartan in Heart Failure
DC Iovanovici, SG Bungau, CM Vesa, M Moisi, EE Babes, DM Tit, ...
International Journal of Molecular Sciences 23 (19), 11336, 2022
52022
Use of anticoagulant drugs in patients with atrial fibrillation. Does adherence to therapy have a prognostic impact?
MM Toma, SG Bungau, DM Tit, MI Moisi, C Bustea, CM Vesa, T Behl, ...
Biomedicine & Pharmacotherapy 150, 113002, 2022
42022
Acute kidney injury incidence and models for mortality prediction in acute coronary syndromes
M Moisi, CM Vesa, S Bungau, DM Tit, RA Corb Aron, O Bratu, ...
Rom. J. Mil. Med 123, 133-140, 2020
42020
Insulin Resistance (IR) in Patients with Type 2 Diabetes Mellitus. Identifying Predictors of Insulin Resistance and Establishing a Correlation Between Insulin Resistance and …
VC Mihai, P Loredana, D Lucia, M Mădălina, P Mircea, R Gabriela, ...
Internal Medicine 15 (2), 7-15, 2018
42018
Clinical profile and management in non-valvular atrial fibrillation and heart failure patients.
OA Tica, O Tica, R Tor, A Hatos, I Cote, MN Brendea, L Rosan, L Mihele, ...
Romanian Journal of Cardiology 28 (1), 2018
42018
Atherosclerosis Burden and Therapeutic Challenges Regarding Acute Coronary Syndromes in Chronic Kidney Disease Patients
MI MOISI, C VESA, LP ROSAN, O TICA, A ARDELEAN, D ZAHA, ...
Maedica A Journal of Clinical Medicine 14 (4), 2019
22019
Morbidity and Mortality in Patients with Acute Coronary Syndrome with and Without Chronic Kidney Disease and Physicans Atitude Regarding Theraphy in the Two Groups
MI Moisi, CM Vesa, L Roșan, O Țica, CD Zaha, A Ardelean, B Katalin, ...
Iranian Journal of Public Health 50 (8), 1726, 2021
12021
INDEPENDENT PREDICTORS FOR THE SEVERITY OF CORONARY ARTERY DISEASE IN PATIENTS WITH MYOCARDIAL INFARCTION WITHOUT ST-SEGMENT ELEVATION.
A Cozma, K Babeș, PM Ioachim, A Ardelean, M Moisi
Internal Medicine/Medicina Interna 17 (2), 2020
12020
Predictors of no-reflow phenomenon: diabetes mellitus type II and obesity and their associated mortality in stemi patients after primary PCI
LR Pantea-Roșan, OA Ţica, M Moisi, VA Pantea, O Ţica, C Vesa, ...
Internal Medicine 16 (4), 7-12, 2019
12019
A Narrative Review of the Classical and Modern Diagnostic Methods of the No-Reflow Phenomenon. Diagnostics 2022, 12, 932
VA Pantea, MI Moisi, CM Vesa, T Behl, AC Nechifor, EE Babes, ...
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022
2022
Proposal of a Novel Risk Score for Determination of Coronary
CM VESA, R Carmen, P Loredana, C JURCA, L DAINA, B Cornelia, ...
Iranian Journal of Public Health, 2020
2020
Proposal of a Novel Risk Score for Determination of Coronary Artery Disease Risk in Newly Diagnosed Diabetes Patients.
CM Vesa, C Radu, L Popa, C Jurca, L Daina, C Bala, G Roman, M Moisi, ...
Iranian Journal of Public Health 49 (8), 1576-1578, 2020
2020
Finding the specific etiology in myocardial infarction with non-obstructive coronary arteries disease (MINOCA) and the best therapeutic approaches–
AI Ardelean, MI Moisi, S Belenes, M Rus, MI Popescu
Romanian Journal of Cardiology| Vol 30 (1), 2020
2020
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20